文献速递慢性肾脏病

尿白蛋白排泄与癌症风险:PREVEND队列研究

Urinary albumin excretion and cancer risk: the PREVEND cohort study.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

本研究基于PREVEND观察性研究纳入8490名受试者,测量基线两次24小时尿白蛋白排泄量,中位随访17.7年。在校正估算肾小球滤过率等多变量后,尿白蛋白排泄每翻倍与总体癌症及尿路癌症发病风险分别升高6%和14%相关,并与总体及肺癌死亡风险升高相关。

要点

  • 尿白蛋白排泄每翻倍,总体癌症发病风险升高6%(HR 1.06,95%CI 1.02-1.10),尿路癌症风险升高14%(HR 1.14,95%CI 1.04-1.24)。
  • 除肺癌和血液系统癌症外,尿白蛋白排泄与其他部位特异性癌症发病无关联。
  • 尿白蛋白排泄每翻倍还与总体死亡及肺癌死亡风险升高相关,独立于基线eGFR。

核心结论

  • 较高的白蛋白尿与总体、尿路、肺及血液系统癌症发病率升高相关,并与总体和肺癌死亡风险升高相关,独立于基线eGFR。

研究设计与样本

  • PREVEND观察性研究,纳入8490名受试者,基线测量两次24小时尿标本的尿白蛋白排泄量,中位随访17.7年。

主要发现

  • 中位基线尿白蛋白排泄为9.4(IQR 6.3-17.8)mg/24h,随访期间1341人发生癌症,其中177例为尿路癌症。
  • 多变量校正(包括eGFR)后,尿白蛋白排泄每翻倍与总体癌症发病风险升高6%(HR 1.06,95%CI 1.02-1.10)及尿路癌症发病风险升高14%(HR 1.14,95%CI 1.04-1.24)相关。
  • 除肺癌和血液系统癌症外,未发现尿白蛋白排泄与其他部位特异性癌症发病相关。
  • 尿白蛋白排泄每翻倍还与总体死亡及肺癌死亡风险升高相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic kidney disease (CKD) is believed to be associated with an increased risk for cancer, especially urinary tract cancer. However, previous studies predominantly focused on the association of decreased estimated glomerular filtration rate (eGFR) with cancer. In this study, we investigated the association of albuminuria with cancer incidence, adjusted for eGFR. METHODS: We included 8490 subjects in the Prevention of Renal and Vascular End-stage Disease (PREVEND) observational study. Urinary albumin excretion (UAE) was measured in two 24-hour urine specimens at baseline. Primary outcomes were the incidence of overall and urinary tract cancer. Secondary outcomes were the incidence of other site-specific cancers, and mortality due to overall, urinary tract, and other site-specific cancers. RESULTS: Median baseline UAE was 9.4 (IQR, 6.3-17.8) mg/24 h. During a median follow-up of 17.7 years, 1341 subjects developed cancer (of which 177 were urinary tract cancers). After multivariable adjustment including eGFR, every doubling of UAE was associated with a 6% (hazard ratios (HR), 1.06, 95% confidence intervals (CI), 1.02-1.10), and 14% (HR, 1.14, 95% CI, 1.04-1.24) higher risk of overall and urinary tract cancer incidence, respectively. Except for lung and hematological cancer, no associations were found between UAE and the incidence of other site-specific cancer. Doubling of UAE was also associated with a higher risk of mortality due to overall and lung cancer. CONCLUSIONS: Higher albuminuria is associated with a higher incidence of overall, urinary tract, lung, and hematological cancer, and with a higher risk of mortality due to overall and lung cancers, independent of baseline eGFR.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Luo L, Kieneker LM, van der Vegt B, et al. Urinary albumin excretion and cancer risk: the PREVEND cohort study. Nephrol Dial Transplant. 2023. PMID: 37226556. doi:10.1093/ndt/gfad107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。